Kiniksa Pharmaceuticals Director Quart Barry D's Contrarian Trades Amid Price Volatility

Kiniksa Pharmaceuticals International, plc, recently disclosed that Director Quart Barry D has made several transactions involving the company's shares. On February 2, 2026, Barry D acquired 830 shares at a price of $15.47 per share. However, the same day, he sold an equal number of shares at $45 per share. The following day, February 3, Barry D purchased 12,528 shares at $15.47 per share, only to sell the same amount at $45.27 per share. On February 4, he acquired 2,602 shares at $15.47 per share, but sold them at $45.02 per share.